Learn More
Medchemexpress LLC cyclo(RLsKDK) | 1975145-82-4 | 98.85% | 727.85 | 1 MG

Supplier: Medchemexpress LLC HYP16761MG
cyclo(RLsKDK) (BK-1361) is a specific inhibitor of metalloproteinase ADAM8, demonstrating an IC50 value of 182 nM. This compound holds potential applications in the treatment of inflammatory diseases and various cancers.
- Specific inhibitor of metalloproteinase ADAM8 (IC50 182 nM).
- Potential applications in inflammatory diseases and cancer research.
- Promotes ADAM8 activation and CD23 shedding.
- Increases activity of pro-ADAM8.
- Induces ERK1/2 phosphorylation in Panc1_ctrl and Panc1_A8 cells.
- Reduces cell invasion in a dose-dependent manner.
- Significantly reduces tumor load and improves survival in PDAC mouse models.
- Decreases soluble ADAM8 content, pERK1/2 activation, and PDAC metastasis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.